uniQure Provides FDA Update on AMT-130; BLA Timing Unclear
uniQure (NASDAQ: QURE) on Nov. 3, 2025 announced FDA feedback…
New gene therapy for Huntington’s ‘changes everything’, say researchers
UK researchers say they have slowed the progression of the fatal neural condition Huntington’s disease for the first…